Results 201 to 210 of about 161,762 (310)
Analysis of factors and pathways influencing patients' level of worry about painless gastrointestinal endoscopy. [PDF]
Zhou L +6 more
europepmc +1 more source
Objective The objective of this study was to compare the long‐term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS). Methods Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from
Gabriel Cerono +3 more
wiley +1 more source
Turning Slowly Predicts Future Diagnosis of Parkinson's Disease: A Decade‐Long Longitudinal Analysis
Objective Wearable technology allows accurate measurement of turning while walking, with cross‐sectional studies indicating that difficulty turning presents even in preclinical phases of Parkinson's disease. The aim of our study was to quantify rate of change of turning performance in a cohort of older adults, and test whether turning decline can ...
Morad Elshehabi +9 more
wiley +1 more source
Impact of variants of uncertain significance on decision making about genetic testing for Hispanic males. [PDF]
Saunders J +9 more
europepmc +1 more source
Brief overview of mpox: To worry or to ignore?
Cokorda Agung Wahyu Purnamasidhi +6 more
openalex +1 more source
Pro‐Inflammatory c‐Met+ CD4 T Cells in Multiple Sclerosis
Objective Hepatocyte growth factor (HGF) binds exclusively the c‐Met surface receptor, and the HGF/c‐Met axis regulates T cell function in autoimmune diseases. We analyzed c‐Met expression on human CD4 T cells in the blood and cerebrospinal fluid (CSF) from patients with multiple sclerosis (MS) versus non‐inflammatory neurological disease (NIND), to ...
Gautier Breville +6 more
wiley +1 more source
Cross-Cultural Adaptation and Validation of the Pediatric Eye Questionnaire in Chinese Children with Uveitis: A Rasch Analysis. [PDF]
Linghu W +5 more
europepmc +1 more source
Play linked to sluggish growth in infant monkeys – but should humans worry?
Phyllis C. Lee
openalex +1 more source
Back Again to the Future: A New Era for Cerebroprotection
Cerebroprotection is a fresh framework for designing neurological therapy that targets glia and vascular cells, in addition to neurons. In the future, successful cerebroprotection will involve targeting all elements of the neurovascular unit. Preclinical trials must include functional outcomes, as well as lesion morphometry.
Patrick Lyden
wiley +1 more source

